Ignite Creation Date:
2024-05-06 @ 6:11 PM
Last Modification Date:
2024-10-26 @ 2:43 PM
Study NCT ID:
NCT05576077
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2022-10-07
Brief Title:
A Study of TBio-4101 TIL and Pembrolizumab in Patients With Advanced Solid Tumors
Sponsor:
Turnstone Biologics Corp
Organization:
Turnstone Biologics Corp
Organization Data
Organization:
Turnstone Biologics Corp
Class:
INDUSTRY
Study ID:
TBio-4101-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Turnstone Biologics Corp
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None